181 ivermectin COVID-19 studies SHOW Unequivocally the Benefits of Ivermectin

181 ivermectin COVID-19 studies SHOW Unequivocally the Benefits of Ivermectin

181 ivermectin COVID-19 studies, 131 peer reviewed, 91 comparing treatment and control groups SHOW Unequivocally the Benefits of Ivermectin for Covid19

New ivermectin study shows 92% lower chance of COVID death

Details Small prospective PSM study in the USA, showing 75% lower mortality with ivermectin treatment, without reaching statistical significance, significantly 

Recent:Qadeer Akhtar Bramante Al-kuraishy Kory Chellasamy Croci. Ivermectin has been officially adopted for early treatment in all or part of 22 countries (38 including non-government medical organizations). Submit updates/corrections.

Ivermectin is currently used for about 27% of the world's population. Countries where COVID-19 mortality is close to zero may not have incentive to adopt treatments. When excluding these countries, ivermectin adoption is about 44%. We excluded countries where the cumulative mortality over the preceding month was less than 1 in 1 million, according to the data at https://ourworldindata.org/). For the estimated population coverage, isolated use, some regions, mixed usage, and many regions use a factor of 0.05, 0.25, 0.5, and 0.75 respectively. Please send us corrections/updates.

GO TO https://c19early.com/ to see all studies from around the globe and find out the REAL FACTS about Covid19 treatments